Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition
1 other identifier
observational
30
1 country
1
Brief Summary
The modified periosteal inhibition technique has been proposed as an alternative to limit crestal resorption following tooth extraction in sockets with a residual vestibular thickness of \<1 mm. This technique aims to prevent osteolytic activity on the external surface of a post-extraction socket by applying a 0.5 mm-thick soft cortical plate of porcine origin, secured with fibrin glue. By avoiding the placement of bone graft material inside the socket, the technique seeks to effectively counteract bone remodeling, achieving minimal reduction in the size of the alveolar crest. The aim is to evaluate the effectiveness of the modified periosteal inhibition technique in preserving the dimensions of the alveolar ridge after tooth extraction, by comparing it with the Biologically-oriented Alveolar Ridge Preservation technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 14, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 22, 2025
January 1, 2025
1.1 years
January 14, 2025
January 17, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
ridge width reduction
optical scanning comparison measured in millimetres at the mid-buccal and mid-palatal aspect of the socket
26 weeks after tooth extraction and preservation tecnhique
ridge height reduction
optical scanning comparison measured in millimetres at the mid-buccal, mid-palatal, mesial and distal aspect of the socket
26 weeks after tooth extraction and preservation tecnhique
Secondary Outcomes (3)
histologic and histomorphometric analysis of new bone formation
26 weeks after tooth extraction and preservation tecnhique
histologic and histomorphometric analysis of residual graft particles
26 weeks after tooth extraction and preservation tecnhique
histologic and histomorphometric analysis of marrow spaces
26 weeks after tooth extraction and preservation tecnhique
Study Arms (2)
BARP
collagen-bonegraft-collagen
Modified Periosteal Inhibition Technique
cortical lamina, human fibrin glue and collagen
Interventions
deep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer
Cortical lamina stabilized with human fibrin glue to preserve the buccal wall of the socket. The socket was then filled with collagen.
Eligibility Criteria
The study will be conducted in an outpatient hospital setting.
You may qualify if:
- Age between 18 and 80 years;
- Single-rooted tooth with indication for extraction with sockets having a residual thickness of \<1 mm in the first 3 mm of the buccal residual crest presenting adjacent teeth;
- American Society of Anesthesiologists 3;
- Periodontal health or stability;
- Signature of informed consent.
You may not qualify if:
- Presence of periapical cystic lesions at the intervention sites;
- Loss of bone tissue extending to the apical third on radiographic examination;
- Extraction of adjacent teeth within a period ranging from 6 months prior to 6 months after the extraction;
- Lack of one or more walls of the post-extraction socket;
- Presence of general contraindications for oral surgery;
- Presence of inflammatory and autoimmune diseases;
- Uncontrolled diabetes (HbA1c 7%);
- History of tumors requiring chemotherapy or radiotherapy in the last 5 years;
- Previous therapy with bisphosphonates or high-dose corticosteroid therapy;
- Smoking (10 cigarettes/day);
- Allergy to bovine collagen;
- Pregnancy or breastfeeding;
- Lack of compliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International Piezosurgery Academylead
- University of Triestecollaborator
Study Sites (1)
University of Trieste
Trieste, TS, 34127, Italy
Biospecimen
alveolar bone specimens withdrawn with trephine bur
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2025
First Posted
January 20, 2025
Study Start
December 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 22, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share